smithkline beckman corp said its genetically engineered hepatitis vaccine has received regulatory approval for marketing switzerland and luxembourg vaccine called engerix has been approved several countries including belgium and hong kong smithkline said currently considering marketing avenues united states merck and also has genetically engineered vaccine being marketed several foreign markets according industry sources reuter 